India’s R&D expenditure is expected to double: Report

In the report titled “Reimagine the future- Life sciences perspective”, JLL has said that the country is looking at a great opportunity to ramp up investments and collaborate with global players in the Pharma & Biotech domain to cater to global needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34nbczl
via IFTTT